This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Social Bookmarking   What's this?

Still an Enigma

Arch Dermatol. 2001;137:1239-1240.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IT IS SOMETIMES a paradox in medicine that rare conditions are intensively studied, while common conditions are often overlooked. Such has been the case with basal cell carcinoma (BCC). The public health burden of BCC is considerable, yet the profile afforded to this cutaneous malignancy is low. This is surprising, as BCC is the most common human cancer.¹ It may be a reflection of the fact that BCC has a very low mortality rate. Using mortality rates as a measure of the importance of BCC in a population, however, will grossly underestimate its importance. Morbidity from this skin cancer is considerable in terms of cosmetic and functional outcome. Increasing numbers of younger individuals are being affected, and treatment consumes considerable medical resources. Morbidity is likely to increase, as, in the white population of North America, the incidence rate of BCC has doubled approximately every 14 years.² Incidence figures for BCC . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Risk Factors for Basal Cell Carcinoma in a Mediterranean Population: Role of Recreational Sun Exposure Early in Life
Rosamaria Corona, Eugenia Dogliotti, Mariarosaria D'Errico, Francesco Sera, Ivano Iavarone, Giannandrea Baliva, Luca M. Chinni, Tommaso Gobello, Cinzia Mazzanti, Pietro Puddu, and Paolo Pasquini
Arch Dermatol. 2001;137(9):1162-1168.
ABSTRACT | FULL TEXT